Journal of Clinical Medicine (Jun 2022)

Hematological- and Immunological-Related Biomarkers to Characterize Patients with COVID-19 from Other Viral Respiratory Diseases

  • Rafael Suárez-Del-Villar-Carrero,
  • Diego Martinez-Urbistondo,
  • Amanda Cuevas-Sierra,
  • Iciar Ibañez-Sustacha,
  • Alberto Candela-Fernandez,
  • Andrea Dominguez-Calvo,
  • Omar Ramos-Lopez,
  • Juan Antonio Vargas,
  • Guillermo Reglero,
  • Paula Villares-Fernandez,
  • Jose Alfredo Martinez

DOI
https://doi.org/10.3390/jcm11133578
Journal volume & issue
Vol. 11, no. 13
p. 3578

Abstract

Read online

COVID-19 has overloaded health system worldwide; thus, it demanded a triage method for an efficient and early discrimination of patients with COVID-19. The objective of this research was to perform a model based on commonly requested hematological variables for an early featuring of patients with COVID-19 form other viral pneumonia. This investigation enrolled 951 patients (mean of age 68 and 56% of male) who underwent a PCR test for respiratory viruses between January 2019 and January 2020, and those who underwent a PCR test for detection of SARS-CoV-2 between February 2020 and October 2020. A comparative analysis of the population according to PCR tests and logistic regression model was performed. A total of 10 variables were found for the characterization of COVID-19: age, sex, anemia, immunosuppression, C-reactive protein, chronic obstructive pulmonary disease, cardiorespiratory disease, metastasis, leukocytes and monocytes. The ROC curve revealed a sensitivity and specificity of 75%. A deep analysis showed low levels of leukocytes in COVID-19-positive patients, which could be used as a primary outcome of COVID-19 detection. In conclusion, this investigation found that commonly requested laboratory variables are able to help physicians to distinguish COVID-19 and perform a quick stratification of patients into different prognostic categories.

Keywords